“…It is a crucial step to better understand the molecular mechanisms underlying the pathogenesis of gastric cancer, which have not been fully elucidated, in order to identify novel prognostic markers and therapeutic targets for the improvement in the low survival outcome and the assistance in the earlier diagnosis of this disease. MicroRNAs (miRNAs), a class of short noncoding RNA molecules with 18 $ 25 nucleotides in length, carry out various biological functions by repressing the expression of their target genes at the post-translational level through base-pairing with endogenous mRNAs [7]. Growing evidence show that miRNAs play important roles in a variety of biological processes related to apoptosis, proliferation, differentiation, metastasis, angiogenesis and immune response, dysregulation of which may be possibly crucial to cancer initiation, progression and treatment outcome [8].…”